Sculthorpe, Nicholas F, McLaughlin, Marie, Cerexhe, Luke et al. · BMJ open · 2025 · DOI
This study followed 287 people in Scotland for 9 months after they had mild COVID-19 to track how long symptoms lasted. By month 9, only 3.1% still had ongoing symptoms matching Long-COVID criteria. Fatigue was the symptom that lasted longest, while cough improved quickly. The study found that older people were more likely to report pain and thinking problems, and women were more likely to experience headaches and post-exertional malaise (feeling worse after activity).
Understanding Long-COVID symptom patterns and recovery timelines is crucial for ME/CFS research, as post-viral conditions share similar characteristics including fatigue and post-exertional malaise. This study's identification of sex and age as risk factors for symptom persistence may help clinicians recognize which patients need closer monitoring and tailored interventions. The finding that fatigue persists longest aligns with ME/CFS pathophysiology and supports the need for targeted management strategies.
This study does not establish causation for why age and gender increase symptom risk—only that associations exist. The 3.1% Long-COVID prevalence applies only to mild acute COVID-19 infections and may not reflect rates in moderate-to-severe acute illness. The study cannot identify which specific biological mechanisms drive prolonged fatigue or post-exertional malaise, nor does it clarify whether Long-COVID and ME/CFS are mechanistically identical.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Sculthorpe, Nicholas F, McLaughlin, Marie, Cerexhe, Luke, Macdonald, Eilidh, Dello Iacono, Antonio, Sanal-Hayes, Nilihan E M, et al. (2025). Tracking Persistent Symptoms in Scotland (TraPSS): a longitudinal prospective cohort study of COVID-19 recovery after mild acute infection.. BMJ open. https://doi.org/10.1136/bmjopen-2024-086646
BibTeX
@article{mecfsatlas-sculthorpe-2025-tracking-persistent,
author = {Sculthorpe, Nicholas F and McLaughlin, Marie and Cerexhe, Luke and Macdonald, Eilidh and Dello Iacono, Antonio and Sanal-Hayes, Nilihan E M and Ingram, Joanne and Meach, Rachel and Carless, David and Ormerod, Jane and Hayes, Lawrence D},
title = {Tracking Persistent Symptoms in Scotland (TraPSS): a longitudinal prospective cohort study of COVID-19 recovery after mild acute infection.},
journal = {BMJ open},
year = {2025},
doi = {10.1136/bmjopen-2024-086646},
note = {PubMed: 39819953},
url = {https://www.mecfsatlas.com/evidence/sculthorpe-2025-tracking-persistent},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-30. https://www.mecfsatlas.com/evidence/sculthorpe-2025-tracking-persistent
Contribute
Private, reviewed by a human. Not a public comment thread.